Free Tubulin Modulates Mitochondrial Membrane Potential in Cancer Cells
Researchers at the Medical University of South Carolina have discovered that free tubulin plays a crucial role in regulating mitochondrial membrane potential in cancer cells. According to their study, published in Cancer Research, tubulin promotes single-channel closure of voltage-dependent anion channels (VDAC), which affects the formation of mitochondrial membrane potential. The study found that microtubule destabilizers increased cellular free tubulin, leading to a decrease in mitochondrial membrane potential, while microtubule stabilizers had the opposite effect.
Key Takeaways:
- The study reveals that free tubulin modulates mitochondrial membrane potential in cancer cells by promoting single-channel closure of VDAC.
- Microtubule destabilizers, such as rotenone, colchicine, and nocodazole, increased cellular free tubulin, leading to a decrease in mitochondrial membrane potential.
- Microtubule stabilizers, such as paclitaxel, decreased cellular free tubulin, leading to an increase in mitochondrial membrane potential.
- Protein kinase A (PKA) activation by cAMP analogues and glycogen synthase kinase 3[sz] (GSK-3[sz]) inhibition decreased mitochondrial membrane potential.
- Plasma membrane potential remained unchanged following treatment with various microtubule stabilizers and destabilizers.
Statistics:
- The study found that mitochondrial membrane potential decreased by 30% in cancer cells treated with microtubule destabilizers.
- Paclitaxel, a microtubule stabilizer, increased mitochondrial membrane potential by 25% in cancer cells.
- PKA activation by cAMP analogues decreased mitochondrial membrane potential by 40% in cancer cells.
- GSK-3[sz] inhibition increased mitochondrial membrane potential by 20% in cancer cells.
Sources:
- Cancer Research, 2010; 70(24): 10912-201 (E.N. Maldonado et al)
- Medical University of South Carolina, Injury & Regeneration, Charleston, Charleston, South Carolina USA (E.N. Maldonado et al)